If yu gɛt wan sik we dɛn kɔl Multiple Sclerosis (MS), yu go dɔn yɛri bɔt wan mɛrɛsin we dɛn kɔl Ocrelizumab. Yu dɔktɔ go dɔn ivin tɛl yu fɔ bigin tek am. So, tide wi go tɔk bɔt wetin na dis drɔg, aw i de wok, ɛn wetin yu nid fɔ no. Bikɔs dis na mɛrɛsin we kɔmplikt smɔl, i go rili impɔtant fɔ mek yu ɔndastand am gud gud wan.
Wetin na dis mɛrɛsin we dɛn kɔl Ocrelizumab?
Fɔ tɔk am simpul wan, Ocrelizumab na wan patikyula mɛrɛsin we dɛn kin yuz fɔ trit wan sik we dɛn kɔl Multiple Sclerosis (MS). I kin kam ɔnda di brand nem OCREVUS.
Naw, we yu gɛt multiple sclerosis (MS), yu bɔdi in yon imyun sistɛm—di sistɛm we de protɛkt yu frɔm sik—de wok pasmak smɔl, ɛn dis kin pwɛl yu yon nervɔs sistɛm. I tan lɛk se yu yon ami de atak yu. So, wetin Ocrelizumab de du na fɔ slo da ɔvaaktiv imyun sistɛm de. Da we de, yu kin kɔntrol ɔ delay fɔ mek yu sik dɛn wɔs. I kin ɛp bak fɔ ridyus di nɔmba fɔ di flare-up.
Bɔt wan tin we wi fɔ mɛmba. Dis nɔto mɛrɛsin fɔ di sik we dɛn kɔl multiple sclerosis (MS). Bɔt, e kin mek am izi fɔ liv wit dis sik. Dis mɛrɛsin de pan wan klas mɛrɛsin we dɛn kɔl monoklɔnal antibodi. dat min se dεn na wan kayn protin we dεn mek na labכtכri we de akt rili spεshal, we de tכk to spεsifi k sεl dεm na di imyun sistεm. spεshal wan, dεn de no כnli di prכblεm sεl dεm εn kכntrol dεn aktiviti.
Sɔntɛnde, dɔktɔ dɛn kin yuz dis mɛrɛsin fɔ ɔda sik, so if yu gɛt ɛni kwɛstyɔn, aks yu dɔktɔ ɔ fama.
Wetin a fɔ tɛl mi dɔktɔ/nɔs bifo a yuz dis mɛrɛsin?
Bikɔs Ocrelizumab na drɔg we nɔ tu strɔng, i rili impɔtant fɔ tɛl yu dɔktɔ ɔr wɛlbɔdi tim bɔt yu wɛlbɔdi bifo yu bigin am. Dis impɔtant mɔ if yu gɛt ɛni wan pan dɛn tin ya:
- Kansa: If yu gɛt kansa naw, ɔ yu dɔn gɛt tritmɛnt fɔ kansa bifo, duya tɛl wi bɔt am.
- Epataytis B infɛkshɔn: If yu bin dɔn gɛt epataytis B bifo, ɔ if yu gɛt epataytis B, yu fɔ tɛl yu dɔktɔ bikɔs i kin tranga mɔ we yu tek dis mɛrɛsin.
- Ɛni kayn infekshɔn:Ɛspɛshali if yu gɛt vayral infɛkshɔn lɛk chikinpoks, hεpi, ɔ ɔda baktriyal infεkshɔn. Dis mɛrɛsin kin mek wan infɛkshɔn we dɔn de, wɔs.
- Tɛl yu dɔktɔ if yu dɔn gɛt alɛji fɔ Ocrelizumab, ɔda mɛrɛsin, it, it day, ɔ tin dɛn we de mek yu nɔ pwɛl .
- If yu gɛt bɛlɛ ɔ yu de tray fɔ gɛt bɛlɛ: Dis rili impɔtant. Dis mɛrɛsin kin ambɔg di pikin we i gɛt bɛlɛ.
- If yu na mama we de gi pikin in mama in bɛlɛ (Breast-feeding): Tɔk to yu dɔktɔ bɔt if dis mɛrɛsin de pas insay yu mama in milk ɛn di ifɛkt dɛn we i kin gɛt.
If yu tɔk dɛn tin ya kɔrɛkt wan, di dɔktɔ go ebul fɔ trit yu fayn fayn wan.
Aw yu kin yuz dis mɛrɛsin?
Ocrelizumab nɔto pil ɔ srɔp we yu kin tek na os. Na injɛkshɔn we dɛn kin put insay wan vein. Dat min se dɛn kin injekt am na di bɔdi, lɛk salin.
Dɛn kin gi dis tritmɛnt na ɔspitul ɔ klinik sɛtin , ɔnda di sɔpɔtishɔn fɔ dɔktɔ ɔ nɔs we tren (keya tim). Dɛn kin sheb di fɔs doz fɔ di mɛrɛsin to tu doz, we dɛn kin gi tu wiks apat. Afta dat, dɛn kin tek di mɛrɛsin wan tɛm ɛvri 6 mɔnt. Bɔt yu dɔktɔ kin chenj dis schedule dipen pan yu kɔndishɔn.
Bifo ɛni tritmɛnt, dɛn go gi yu wan spɛshal instrɔkshɔn liflet (MedGuide) fɔ rid. I gɛt infɔmeshɔn bɔt dis mɛrɛsin, di sayd ɛfɛkt dɛn, ɛn tin dɛn we yu fɔ no bɔt. I rili impɔtant fɔ tek tɛm rid am ɛni tɛm.
If yu de gi dis mɛrɛsin to pikin dɛn, yu fɔ tek tɛm spɛshal. Tɔk to yu mɛdikal tim bɔt am.
Tink bɔt am lɛk se spɛshal dɔktɔ de kam insay ɛn tek tɛm gi mɛrɛsin to di say we yu gɛt prɔblɛm na yu bɔdi. Na dat mek dɛn kin gi am na ɔspitul, ɔnda dɔktɔ in sɔpɔtishɔn.
Ovados: Dis nɔ kin apin bikɔs dɛn kin gi dis ɔnda dɔktɔ in sɔpɔtishɔn. Bɔt if yu tink se dis dɔn apin, kɔl pɔyzin kɔntrol sɛnta ɔ imejensi rum wantɛm wantɛm.
Dis mɛrɛsin na fɔ yu nɔmɔ: Dis na mɛrɛsin wae dɛn kin gi yu fɔ yu sik ɛn yu bɔdi. So, nɔ ɛva sheb dis mɛrɛsin wit ɔda pipul dɛn.
Wetin yu kin du if yu mis apɔntinmɛnt fɔ tek mɛrɛsin?
Bikɔs dis na mɛrɛsin we dɛn kin gi yu pan schedule, i rili impɔtant fɔ kip yu apɔntinmɛnt dɛn. I nɔ fayn fɔ mis wan doz.
If, fɔ ɛni rizin, yu nɔ ebul fɔ atɛnd di de we yu dɔn sɛtul, duya kɔl yu mɛdikal tim wantɛm wantɛm ɛn mek dɛn no.Dɔn dɛn go gi yu ɔda de.
Us ɔda tin dɛn kin miks wit dis mɛrɛsin? (Intarakshɔn dɛn)
Ocrelizumab kin intarakt wit ɔda mɛrɛsin, vaysin, ɔ ɔda tin dɛn we yu de tek. Dis min se e kin afɛkt aw di mɛrɛsin de wok fayn ɔr kin mek yu gɛt sayd ɛfɛkt.
So, bifo yu bigin tek dis mɛrɛsin, yu fɔ tɛl yu dɔktɔ bɔt ɔltin we yu de yuz. Dat min se:
- Ɛni ɔda mɛrɛsin we yu de tek (mɛrɛsin fɔ ɔda sik, pen kil, vaytamɛn, Ayurveda mɛrɛsin, homyopatik mɛrɛsin, ɛn ɔda tin dɛn).
- Di dietary supliment dɛn we yu de tek.
- Mek shɔ se yu tɛl dɛn if yu de smok, drink rɔm, ɔ yuz ɔda drɔgs .
Na mɔ, ɔda mɛrɛsin dɛn we de afɛkt di imyun sistɛm (e.g., Alemtuzumab, Fingolimod, Rituximab, stɛroyd), ɛn sɔm vaysin dɛn (espɛshali layf vayrɔs vaysin dɛn) kin intarakt wit dis mɛrɛsin. So, i bɛtɛ fɔ gi yu dɔktɔ wan list fɔ ɔl di mɛrɛsin ɛn sɔpɔtmɛnt dɛn we yu de tek. Dis list nɔ kɔmplit, so i impɔtant fɔ tɛl dɛn ɔltin.
Wetin wi fɔ tek tɛm mɔ we wi de tek dis mɛrɛsin?
Yu mɛdikal tim go de wach yu wɛlbɔdi gud gud wan we yu de tek Ocrelizumab. I impɔtant bak fɔ mek yu no bɔt dɛn tin ya:
- Siriɔs alɛji: Sɔm pipul dɛn kin gɛt siriɔs alɛji we dɛn de tek dis mɛrɛsin ɔ afta dɛn dɔn tek am. Fɔ ridyus dis risk, dɛn kin gi yu ɔda mɛrɛsin (lɛk antihistamine ɔ steroid) bifo yu tek dis mɛrɛsin. Fɔ fala yu dɔktɔ in instrɔkshɔn dɛn di rayt we.
- Bɛlɛ ɛn kɔntrasepshɔn: If yu de plan fɔ gɛt bɛlɛ ɔ yu tink se yu go gɛt bɛlɛ, tɛl yu dɔktɔ wantɛm wantɛm. Dis mɛrɛsin kin mek dɛn bɔn siriɔs prɔblɛm. So, i impɔtant fɔ yuz fayn fayn kɔntrasepshɔn we yu de tek dis mɛrɛsin ɛn fɔ 6 mɔnt afta yu dɔn stɔp di mɛrɛsin.
- Di risk fɔ gɛt infɛkshɔn kin bɔku: Dis mɛrɛsin kin mek di imyun sistɛm nɔ wok fayn, we kin mek yu gɛt difrɛn infɛkshɔn. If yu gɛt sɔm sayn dɛn lɛk fiva, kol, trot we de at, kɔf, ɔ kol, nɔr de mɛn yusɛf ɛn kɔl yu dɔktɔ wantɛm wantɛm fɔ advays. Tray fɔ de fa frɔm pipul dɛn we sik as yu ebul.
- Di epataytis B stetmɛnt:If yu dɔn gɛt epataytis B bifo ɛn yu de tink fɔ stɔp dis mɛrɛsin, tɔk to yu dɔktɔ bɔt am, bikɔs di epataytis B simptom kin wɔs bak afta yu dɔn stɔp di mɛrɛsin.
- Siriɔs bren infɛkshɔn: Insay sɔm sik pipul dɛm, pan ɔl we i nɔ kin bɔku, dis mɛrɛsin kin mek dɛn gɛt siriɔs bren infɛkshɔn (Progressive Multifocal Leukoencephalopathy - PML). Dis kin kil pɔsin. If yu gɛt ɛni wan pan dɛn sayn ya, lɛk wae yu nɔr de si fayn, yu nɔr de tink fayn, yu nɔr kin ebul fɔ tɔk, yu nɔr kin ebul fɔ waka ɔr tinap, ɔr yu nɔr kin ebul fɔ balans, tɛl yu wɛl bɔdi tim wantɛm wantɛm. If yu nɔ ebul fɔ rich to dɛn, go to ɔda dɔktɔ wantɛm wantɛm. Dis na imejensi.
- Di rεspכns to vaysin dεm we de dכn: We yu de tek dis mεdisin, yu bכdi kin rεspכnd bכku bכku wan to vaysin. If yu nid fɔ gɛt ɛni vaysin, tɛl yu dɔktɔ se yu de tek dis mɛrɛsin. Yu kin nid ɛkstra bɔsta dos ɔ difrɛn vaksin schedule.
- Risk fɔ gɛt kansa: Sɔm stɔdi dɔn sho se if yu tek dis mɛrɛsin, i kin mek yu gɛt sɔm kayn kansa smɔl (e.g., brɔst kansa). So tɔk to yu dɔktɔ bɔt yu kansa risk. Mek shɔ se yu de du yu brɔst sɛlf-ɛgzam ɛn mamogram ɔltɛm.
Wetin na di sayd ɛfɛkt dɛm we dis mɛrɛsin kin gɛt? (Sayd Ɛfɛkt dɛn)
Lɛk ɛni mɛrɛsin, Ocrelizumab kin mek sɔm sayd ɛfɛkt. Nɔto ɔlman kin gɛt dɛn, bɔt i fayn fɔ no bɔt dɛn.
Di sayd ɛfɛkt dɛm we yu fɔ tɛl yu dɔktɔ wantɛm wantɛm:
If yu gɛt ɛni wan pan dɛn sik ya, nɔ de te ɛn tɛl yu mɛdikal tim wantɛm wantɛm:
- Alɛji riakshɔn: skin de rɔsh, it, ayv, swel na yu fes, lip, tɔŋ, ɔ trot – dis kin mek i nɔ izi fɔ blo.
- di brεst tisu chenj: Nyu lumps na di brεst, rεd, pen, dischaj frכm di nipl. Dɛn tin ya kin afɛkt man dɛn bak.
- Diziz, nɔr de balans ɔr kɔdineshɔn, kɔnfyushɔn ɔr trɔbul fɔ tɔk.
- Di sayn dɛm fɔ Infɛkshɔn: fiva, kol, kɔf, trot we de at, wund dɛm we nɔ de wɛl, pen ɔ trɔbul we yu de pas urine, jenɛral filin fɔ diskɔmfɔt ɔr nɔr wɛl.
- Di riakshɔn dɛn we pɔsin kin gɛt we i de put infushɔn:Chɛst pen, yu nɔ de blo shɔt ɔ yu gɛt prɔblɛm fɔ blo, yu de fil lɛk yu nɔ gɛt bɛtɛ trɛnk ɔ yu gɛt layt. Dɛn tin ya kin apin we yu tek di mɛrɛsin ɔ insay 24 awa.
- Di sayn dɛm fɔ di liva injuri: di rayt ɔpa bɛlɛ de pen, yu nɔ de want fɔ it, yu nɔ de fil fayn, yu stɔl gɛt layt kɔlɔ, yu de urine dak yɔlɔ ɔ brawn, yu skin ɔ yu yay de yɔlɔ, yu wik ɔ taya we nɔ kɔmɔn.
- Bɛlɛ pen wantɛm wantɛm ɔ bad bad wan, blɔd dayarɛa, fiva, nɔs, vɔmit.
Sayd ɛfɛkt dɛm wae yu nɔr kin nid fɔ tɛl yu dɔktɔ bɔt, bɔt yu fɔ ripɔt if dɛn kɔntinyu ɔr de mɔna yu:
Pan ɔl we dɛn tin ya nɔ kin rili siriɔs, tɛl yu dɔktɔ if dɛn kɔntinyu fɔ de ɔ de mɔna yu:
- Bak pen
- Rɔnbɛlɛ
- Di anklɛ, an, ɔ fut kin swel
- Di mud we de wɔs, filin fɔ fil bad
Mɛmba se dis list nɔ gɛt ɔl di bad tin dɛn we kin apin. If yu gɛt ɛni ɔda sayn we nɔ kɔmɔn, tɔk to yu dɔktɔ bɔt dɛn bak.
Usay dɛn kin kip dis mɛrɛsin? (Usay fɔ kip)
Dis na kwɛstyɔn we bɔku pipul dɛn kin aks. Bɔt Ocrelizumab nɔto mɛrɛsin we yu kin kɛr go na os. Na mɛrɛsin we dɛn kin gi yu na ɔspitul ɔ klinik, we dɛn kin kip ɔnda di tɛmpracha kɔntrol we dɛn nid, ɛn gi yu di rayt tɛm. So yu nɔ nid fɔ wɔri bɔt aw fɔ kip am na os.
Sɔm tin dɛn we a tink se impɔtant fɔ yu (Take-Home Message)
Okay, so wi don tok plenti boht Ocrelizumab, no so? Fɔ dɔn, a gɛt dis fɔ tɛl una:
- Ocrelizumab na wan spɛshal ɛn pawaful mɛrɛsin fɔ di sik we dɛn kɔl multiple sclerosis (MS).
- Bifo yu bigin dis mɛrɛsin, i impɔtant fɔ tɛl yu dɔktɔ ɔltin bɔt yu wɛlbɔdi prɔblɛm ɛn ɔl di mɛrɛsin dɛn we yu de tek. Nɔ ayd ɛnitin.
- Kip yu apɔntinmɛnt dɛn di rayt tɛm we yu de tek di mɛrɛsin.
- If yu gɛt ɛni ɔda tin we nɔ kɔmɔn, mɔ di sayn dɛn we de sho se yu gɛt infekshɔn, alɛji, ɔ sayn dɛn we kin gɛt fɔ du wit yu bren infɛkshɔn, tɛl yu dɔktɔ wantɛm wantɛm.
- If yu de tink bɔt fɔ gɛt bɛlɛ, yu gɛt bɛlɛ, ɔ yu de gi pikin in bɛlɛ, mek shɔ se yu tɔk to yu dɔktɔ bɔt dis mɛrɛsin. Yuz fayn bɔn kɔntrol we yu de tek di mɛrɛsin ɛn fɔ 6 mɔnt afta yu dɔn stɔp.
- Yu gɛt ɛni kwɛstyɔn bɔt dis mɛrɛsin?If yu gɛt kwɛstyɔn ɔ dawt, nɔ shem fɔ aks yu dɔktɔ, nɔs, ɔ fama.
Fɔ liv wit di sik we dɛn kɔl multiple sclerosis (MS) kin tranga. Bɔt, wit di mɔdan tritmɛnt dɛm lɛk Ocrelizumab, yu kin ɛp fɔ kɔntrol di sik ɛn liv bɛtɛ kwaliti layf. Nɔto yu wan de, ɛn yu gɛt wan tim we de ɛp yu. So, tek at!
` ocrelizumab, mכltipכl sklεrosis, MS, כkrevus, monoklonal antibodi, imyun sistεm, sayd ifekt, injεkshכn, nyurolכjik sik dεm, imyun sistεm, mכltipכl sklεrosis tritmεnt
💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt